| Literature DB >> 26590300 |
Yoshiko Komatsu1, Yuki Yanagisawa1, Maya Moriizumi2, Yuuki Tsuchiya2, Honami Yokouchi2, Hatsumi Otsuka2, Mizuki Aoyagi2, Akiko Tsukada1, Yukiko Kanai1, Ayumi Haneishi2, Katsuhiro Takagi3, Kosuke Asano2, Moe Ono4, Takashi Tanaka5, Koji Tomita5, Kazuya Yamada6.
Abstract
The 5'-AMP-activated protein kinase (AMPK) functions as a cellular energy sensor. 5-Aminoimidazole-4-carboxyamide-1-β-D-ribofranoside (AICAR) is a chemical activator of AMPK. In the liver, AICAR suppresses expression of thephosphoenolpyruvate carboxykinase(PEPCK) gene. The rat enhancer of split- and hairy-related protein-2 (SHARP-2) is an insulin-inducible transcriptional repressor and its target is thePEPCKgene. In this study, we examined an issue of whether theSHARP-2gene expression is regulated by AICAR via the AMPK. AICAR increased the level of SHARP-2 mRNA in H4IIE cells. Whereas an AMPK inhibitor, compound-C, had no effects on the AICAR-induction, inhibitors for both phosphoinositide 3-kinase (PI 3-K) and protein kinase C (PKC) completely diminished the effects of AICAR. Western blot analyses showed that AICAR rapidly activated atypical PKC lambda (aPKCλ). In addition, when a dominant negative form of aPKCλ was expressed, the induction of SHARP-2 mRNA level by AICAR was inhibited. Calcium ion is not required for the activation of aPKCλ. A calcium ion-chelating reagent had no effects on the AICAR-induction. Furthermore, the AICAR-induction was inhibited by treatment with an RNA polymerase inhibitor or a protein synthesis inhibitor. Thus, we conclude that the AICAR-induction of theSHARP-2gene is mediated at transcription level by a PI 3-K/aPKCλ pathway.Entities:
Keywords: 5′-AMP-activated protein kinase; AICAR; SHARP-2; atypical protein kinase C lambda; insulin-inducible transcriptional repressor
Mesh:
Substances:
Year: 2015 PMID: 26590300 PMCID: PMC4885932 DOI: 10.1093/jb/mvv116
Source DB: PubMed Journal: J Biochem ISSN: 0021-924X Impact factor: 3.387